Find the answer for Sonnet's last six lines from the people who brought you the USA TODAY Daily Crossword Puzzle.

Compare plans for Claude Code in this pricing and features breakdown. Discover which plan fits your needs and budget, this in ...

Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday a $888 million merger agreement with Rorschach I LLC, an ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

Sonnet BioTherapeutics (NASDAQ:SONN) saw its stock soar by 290% after announcing an $888 million business combination that will pivot the company into a cryptocurrency treasury focused on HYPE tokens.

Internal docs show xAI paid contractors to "hillclimb" Grok's rank on a coding leaderboard above Anthropic's Claude.

The company described Claude Opus 4 as the “world’s best coding model” when it launched in May. The LLM set a new record on ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Sonnet BioTherapeutics will transform into a new entity called HyperLiquid Strategies at the agreement's close. The new company is expected to hold 12.6 million HYPE tokens and gross cash invested of ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Claude 3.5 Sonnet was able to solve 64% of problems related to bug fixing and functionality additions with open source codebases, a significant improvement over Claude 3 Opus’ 38% success rate.